DIANA SM BUIST

Summary

Affiliation: Group Health Cooperative
Country: USA

Publications

  1. ncbi Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence
    Diana S M Buist
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 21:720-7. 2012
  2. ncbi Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49
    Deborah Casso
    Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Health Qual Life Outcomes 2:25. 2004
  3. ncbi Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study
    Soe Soe Thwin
    Geriatrics Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
    BMC Med Res Methodol 7:23. 2007
  4. ncbi Factors contributing to mammography failure in women aged 40-49 years
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    J Natl Cancer Inst 96:1432-40. 2004
  5. ncbi The relationship between breast density and bone mineral density in postmenopausal women
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer 101:1968-76. 2004
  6. ncbi A population-based osteoporosis screening program: who does not participate, and what are the consequences?
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    J Am Geriatr Soc 52:1130-7. 2004
  7. ncbi Short-term hormone therapy suspension and mammography recall: a randomized trial
    Diana S M Buist
    Group Health Center for Health Studies, University of Washington, and Group Health Permanente, 125 16th Avenue East, Seattle, WA 98112, USA
    Ann Intern Med 150:752-65. 2009
  8. ncbi Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence
    Diana S M Buist
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Clin Oncol 27:4508-14. 2009
  9. ncbi Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States)
    D S Buist
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer Causes Control 12:213-22. 2001
  10. ncbi Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care
    Diana S M Buist
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Clin Oncol 25:3428-36. 2007

Research Grants

Detail Information

Publications75

  1. ncbi Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence
    Diana S M Buist
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 21:720-7. 2012
    ..We longitudinally examined women and compared mammography use and cancer rates by HT use [current, former, and never users of estrogen + progestin (EPT) and estrogen only (ET)]...
  2. ncbi Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49
    Deborah Casso
    Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Health Qual Life Outcomes 2:25. 2004
    ..The purpose of this report is to examine the correlates of quality of life (QOL) of a well-defined group of long-term breast cancer survivors diagnosed between the ages of 40 and 49...
  3. ncbi Automated inter-rater reliability assessment and electronic data collection in a multi-center breast cancer study
    Soe Soe Thwin
    Geriatrics Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
    BMC Med Res Methodol 7:23. 2007
    ..There remains a need to examine potential benefits, efficiencies, and innovations associated with an EDC system in a multi-center medical record review study...
  4. ncbi Factors contributing to mammography failure in women aged 40-49 years
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    J Natl Cancer Inst 96:1432-40. 2004
    ..We explored the effect of tumor growth rate, breast density, mammographic image quality, and breast cancer risk factors on mammographic sensitivity in younger and older women...
  5. ncbi The relationship between breast density and bone mineral density in postmenopausal women
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer 101:1968-76. 2004
    ..The authors examined the relationship between bone mineral density (BMD; a marker of lifetime estrogen exposure) and breast density...
  6. ncbi A population-based osteoporosis screening program: who does not participate, and what are the consequences?
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    J Am Geriatr Soc 52:1130-7. 2004
    ..To describe differences in osteoporosis risk factors and rates of fracture and antiresorptive therapy use in women who did and did not participate in an osteoporosis screening program...
  7. ncbi Short-term hormone therapy suspension and mammography recall: a randomized trial
    Diana S M Buist
    Group Health Center for Health Studies, University of Washington, and Group Health Permanente, 125 16th Avenue East, Seattle, WA 98112, USA
    Ann Intern Med 150:752-65. 2009
    ..Hormone therapy increases breast density, and abnormal screening mammograms are more common among women with denser breasts and among women using hormone therapy...
  8. ncbi Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence
    Diana S M Buist
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Clin Oncol 27:4508-14. 2009
    ..Some women with early-stage breast cancer are at higher risk of recurrence and can benefit from chemotherapy. We describe patterns of referral, receipt, and completion of chemotherapy among older women at high risk of recurrence...
  9. ncbi Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States)
    D S Buist
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer Causes Control 12:213-22. 2001
    ....
  10. ncbi Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care
    Diana S M Buist
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    J Clin Oncol 25:3428-36. 2007
    ..The purpose of this study was to examine the association between BMI at breast cancer diagnosis and receipt of appropriate primary tumor therapy and adjuvant therapy...
  11. ncbi Identifying postmenopausal women at high risk of fracture in populations: a comparison of three strategies
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative of Puget Sound, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    J Am Geriatr Soc 50:1031-8. 2002
    ..A key study objective was to compare the proportion of postmenopausal women at high risk of fracture in a managed care population using several different definitions of who is at high risk...
  12. ncbi Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer
    Diana S M Buist
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    Breast Cancer Res Treat 124:863-73. 2010
    ..This study does not provide any evidence in support of changing surveillance intervals for different subgroups...
  13. ncbi Influence of annual interpretive volume on screening mammography performance in the United States
    Diana S M Buist
    Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Radiology 259:72-84. 2011
    ..To examine whether U.S. radiologists' interpretive volume affects their screening mammography performance...
  14. ncbi Mammographic breast density, dense area, and breast area differences by phase in the menstrual cycle
    Diana S M Buist
    Group Health Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 15:2303-6. 2006
    ..Mammographic breast density may be greater in the luteal phase (days 15-30) than the follicular phase (days 1-14) of the menstrual cycle; this may have implications for when mammography screening should occur...
  15. ncbi Hormone therapy prescribing patterns in the United States
    Diana S M Buist
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Obstet Gynecol 104:1042-50. 2004
    ....
  16. ncbi Prospective breast cancer risk prediction model for women undergoing screening mammography
    William E Barlow
    Cancer Research and Biostatistics, 1730 Minor Avenue, Suite 1900, Seattle, WA 98101, USA
    J Natl Cancer Inst 98:1204-14. 2006
    ..We used prospective risk information to predict a diagnosis of breast cancer in a cohort of 1 million women undergoing screening mammography...
  17. ncbi Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy
    Joann G Elmore
    Department of Medicine, University of Washington School of Medicine, Harborview Medical Center, 325 Ninth Ave, Box 359780, Seattle, WA 98104 2499, USA
    Radiology 253:641-51. 2009
    ..To identify radiologists' characteristics associated with interpretive performance in screening mammography...
  18. ncbi Short-term (1-2 mo) hormone therapy cessation before mammography
    Susan D Reed
    Group Health Center for Health Studies, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA
    Menopause 16:1125-31. 2009
    ..Some healthcare providers recommend hormone therapy (HT) cessation before mammography to improve performance. Our objective was to evaluate characteristics of women willing to consider HT cessation before screening mammography...
  19. ncbi Varying levels of family history of breast cancer in relation to mammographic breast density (United States)
    Anthony B Crest
    Institute for Public Health Genetics, University of Washington, Seattle, WA, USA
    Cancer Causes Control 17:843-50. 2006
    ..There may be common, yet undiscovered, genetic elements that affect breast cancer and mammographic breast density...
  20. ncbi Evaluation of three population-based strategies for fracture prevention: results of the osteoporosis population-based risk assessment (OPRA) trial
    Andrea Z LaCroix
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Med Care 43:293-302. 2005
    ..The integration of bone density testing into well-designed fracture prevention programs that can be applied in populations has not been studied...
  21. ncbi Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?
    Stephen H Taplin
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Cancer Epidemiol Biomarkers Prev 13:225-34. 2004
    ..Addressing the concerns of un-enrolled women and those without mammograms offers an opportunity for further late-stage disease reduction...
  22. ncbi Biennial versus annual mammography and the risk of late-stage breast cancer
    Emily White
    School of Public Health, University of Washington, Seattle, WA, USA
    J Natl Cancer Inst 96:1832-9. 2004
    ..Mammography screening may reduce breast cancer mortality by detecting cancers at an earlier stage. However, certain questions remain, including the ideal interval between mammograms...
  23. ncbi The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program
    Nina Oestreicher
    Pharmaceutical Outcome Research and Policy Program, University of Washington School of Pharmacy, Center for Cost and Outcomes Research, Seattle, WA 98195, USA
    AJR Am J Roentgenol 184:428-32. 2005
    ..The objective of this study was to determine the potential added contribution of clinical breast examination (CBE) to invasive breast cancer detection in a mammography screening program, by categories of age and breast density...
  24. ncbi Statin use and breast cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 16:416-21. 2007
    ..Mechanistic studies suggest that 3-hydroxy-3-methylglutaryl CoA inhibitors (statins) reduce the risk of breast cancer. Observational studies offer mixed results...
  25. ncbi Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network
    Erin J Aiello
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Breast Cancer Res Treat 107:397-403. 2008
    ..We evaluated diffusion of aromatase inhibitor dispensings for breast cancer treatment in integrated healthcare delivery systems across the United States...
  26. ncbi Timing of follow-up after abnormal screening and diagnostic mammograms
    Karen J Wernli
    Group Health Research Institute, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Am J Manag Care 17:162-7. 2011
    ..To evaluate woman-level characteristics associated with timing of follow-up after abnormal mammograms in an integrated healthcare system with an active breast health program...
  27. ncbi Accuracy of screening mammography varies by week of menstrual cycle
    Diana L Miglioretti
    Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Radiology 258:372-9. 2011
    ..To investigate sensitivity, specificity, and cancer detection rate of screening mammography according to week of menstrual cycle among premenopausal women...
  28. ncbi Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension
    Erin J Aiello Bowles
    Group Health Research Institute, Group Health Cooperative, Seattle, Washington 98101, USA
    J Womens Health (Larchmt) 19:1467-74. 2010
    ..We hypothesized that women with dense breasts might have lower tolerance for short-term HT suspension than do women with fatty breasts...
  29. ncbi Breast cancer recurrence risk in relation to antidepressant use after diagnosis
    Jessica Chubak
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101 1448, USA
    Breast Cancer Res Treat 112:123-32. 2008
    ....
  30. ncbi Radiologist characteristics associated with interpretive performance of diagnostic mammography
    Diana L Miglioretti
    Group Health Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    J Natl Cancer Inst 99:1854-63. 2007
    ..Extensive variability has been noted in the interpretive performance of screening mammography; however, less is known about variability in diagnostic mammography performance...
  31. ncbi Antidepressant medications and change in mammographic density in postmenopausal women
    Jessica Chubak
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Cancer Epidemiol Biomarkers Prev 18:676-9. 2009
    ..Several studies suggest antidepressant medications can increase prolactin levels. Some, but not all, studies suggest prolactin levels are positively associated with mammographic breast density, an established risk factor for breast cancer...
  32. ncbi Statin use and female reproductive organ cancer risk in a large population-based setting
    Onchee Yu
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 20:609-16. 2009
    ..We evaluated the association between statin use and endometrial as well as ovarian cancer risks...
  33. ncbi Hormone therapy initiation after the Women's Health Initiative
    Katherine M Newton
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    Menopause 15:487-93. 2008
    ..To describe hormone therapy (HT) initiation after the 2002 publication of the Women's Health Initiative...
  34. ncbi Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography
    Constance D Lehman
    Department of Radiology, University of Washington Medical Center, Seattle Cancer Care Alliance, 825 Eastlake Ave E, G2 600, PO Box 19023, Seattle, WA 98109 1023, USA
    AJR Am J Roentgenol 190:511-5. 2008
    ....
  35. ncbi Statin use and prostate cancer risk in a large population-based setting
    Denise M Boudreau
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 19:767-74. 2008
    ..Statins are a commonly used cholesterol-lowering drug, which also have the potential to affect cancer risk and progression. Results from previous studies offer mixed conclusions...
  36. ncbi When radiologists perform best: the learning curve in screening mammogram interpretation
    Diana L Miglioretti
    Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Radiology 253:632-40. 2009
    ..To examine changes in screening mammogram interpretation as radiologists with and radiologists without fellowship training in breast imaging gain clinical experience...
  37. ncbi Impact of hormone therapy on false-positive recall and costs among women undergoing screening mammography
    Denise M Boudreau
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101 1448, USA
    Med Care 44:62-9. 2006
    ..We sought to evaluate the effects of hormone therapy (HT) on false-positive (FP) recall for additional breast evaluation and costs...
  38. ncbi The influence of statin use on breast density
    Denise M Boudreau
    Group Health Cooperative, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 15:1026-9. 2006
    ..To evaluate if 3-hydroxy-3-methylglutaryl CoA reductase reductase inhibitor use (statins) alters mammography measured breast density...
  39. ncbi The impact of comorbidities on hormone use. After the 2000 release of the Women's Health Initiative
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    J Gen Intern Med 20:350-6. 2005
    ....
  40. ncbi Association between mammographic breast density and breast cancer tumor characteristics
    Erin J Aiello
    Group Health Cooperative, Center for Health Studies, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 14:662-8. 2005
    ..We examined the association between hormonal, proliferative, and histologic tumor characteristics and mammographic breast density in women with breast cancer...
  41. ncbi Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms
    Erin J Aiello
    Group Health Cooperative, Center for Health Studies, Seattle, WA 98101, USA
    J Am Board Fam Pract 17:408-15. 2004
    ..Breast cancer rates in women with multiple breast symptoms have not been well described...
  42. ncbi Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States)
    Erin J Aiello
    Group Health Center for Health Studies, Suite 1600, Seattle, WA 98101, USA
    Cancer Causes Control 17:1227-35. 2006
    ..To evaluate whether the association between hormone therapy (HT) and breast density differs by levels of breast cancer risk factors...
  43. ncbi Use of alternative therapies for menopause symptoms: results of a population-based survey
    Katherine M Newton
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Obstet Gynecol 100:18-25. 2002
    ..To describe self-reported prevalence of the use of alternative therapies for menopause symptoms and subject characteristics associated with their use...
  44. ncbi Mediating factors in the relationship between income and mammography use in low-income insured women
    Alice N Park
    Urban Indian Health Institute, Seattle Indian Health Board, Seattle, Washington, USA
    J Womens Health (Larchmt) 17:1371-8. 2008
    ....
  45. ncbi No effect of aspirin on mammographic density in a randomized controlled clinical trial
    Anne McTiernan
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 18:1524-30. 2009
    ....
  46. ncbi Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history
    Megan L Welsh
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Breast Cancer Res Treat 114:549-58. 2009
    ..We provide population-based estimates of breast cancer risk and different tumor subtypes in relation to the degree, number, and age at diagnosis of affected relatives...
  47. ncbi Radiologists' attitudes and use of mammography audit reports
    Joann G Elmore
    Division of General Internal Medicine, 325 Ninth Avenue, University of Washington, Seattle, WA 98104, USA
    Acad Radiol 17:752-60. 2010
    ..The objectives of our study were to assess the content and style of audits and examine use of, attitudes toward, and perceptions of the value that radiologists' have regarding mandated medical audits...
  48. ncbi Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population
    Amanda I Phipps
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 19:1643-54. 2010
    ..We compared associations between several factors and risk of ductal, lobular, and mixed ductal-lobular breast cancers...
  49. ncbi Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting
    Amanda I Phipps
    Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA 98195, USA
    Menopause 16:576-81. 2009
    ..Classification of menopause status often relies on self-report and is centrally important to research and clinical practice. This study was designed to assess the validity of self-reported hysterectomy and oophorectomy...
  50. ncbi Low frequency of treatment of osteoporosis among postmenopausal women following a fracture
    Susan E Andrade
    Meyers Primary Care Institute-Fallon Healthcare System and University of Massachusetts Medical School, Worcester, MA 01605, USA
    Arch Intern Med 163:2052-7. 2003
    ..Interventions to improve the detection and treatment of osteoporosis in high-risk patients need to be developed...
  51. ncbi Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population
    Karla Kerlikowske
    San Francisco Veterans Affairs Medical Center, General Internal Medicine Section, 111A1, 4150 Clement St, San Francisco, CA 94121, USA
    J Clin Oncol 21:4314-21. 2003
    ..We determined the risk of breast cancer and tumor characteristics among current postmenopausal hormone therapy users compared with nonusers, by duration of use...
  52. ncbi Chronic disease score as a predictor of hospitalization
    Kathleen G Putnam
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Epidemiology 13:340-6. 2002
    ..9 to 10.2. CONCLUSIONS: The Chronic Disease Score predicts hospitalization and therefore may be a useful indicator of baseline comorbidity for control of confounding...
  53. ncbi Previous pregnancy outcome and breast density (United States)
    Amira Y El-Bastawissi
    Offices of Epidemiology and Community Wellness and Prevention, Washington State Department of Health, MS 47839, Olympia, WA 98504 7839, USA
    Cancer Causes Control 16:407-17. 2005
    ..We evaluated the association of pre-term delivery (PTD), low birth weight (LBW), and fetal death with breast density by age at mammogram and years since birth...
  54. ncbi Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use
    Jennifer S Haas
    Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120 1613, USA
    J Gen Intern Med 22:68-73. 2007
    ..The news media facilitated the rapid dissemination of the findings from the estrogen plus progestin therapy arm of the Women's Health Initiative (EPT-WHI)...
  55. ncbi Evaluation of decision rules to identify postmenopausal women for intervention related to osteoporosis
    Susan K Brenneman
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania 19486, USA
    Dis Manag 6:159-68. 2003
    ..The appropriate selection of a screening tool depends upon the objective for intervention and trade-off between not identifying women for BMD testing who are at high risk and identifying more women for BMD testing who are at low risk...
  56. ncbi Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk
    Karla Kerlikowske
    Department of Epidemiology and Biostatistics, Department of Veterans Affairs, University of California, San Francisco, CA, USA
    J Natl Cancer Inst 99:386-95. 2007
    ..Whether a change over time in clinically measured mammographic breast density influences breast cancer risk is unknown...
  57. ncbi Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women
    Mary Beth Terry
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    Cancer Epidemiol Biomarkers Prev 17:1088-95. 2008
    ..Use of nonsteroidal anti-inflammatory drugs (NSAID) has been associated with a decrease in breast cancer risk, but it is unknown if they also reduce mammographic density, a strong intermediate marker of breast cancer risk...
  58. ncbi Recurrences and second primary breast cancers in older women with initial early-stage disease
    Ann M Geiger
    Division of Public Health Sciences, Department of Social Sciences and Health Policy, Wake Forest University Health Sciences, Winston Salem, North Carolina 27157, USA
    Cancer 109:966-74. 2007
    ..The association between common breast cancer therapies and recurrences and second primary breast cancers in older women is unclear, although older women are less likely to receive common therapies...
  59. ncbi Factors associated with imaging and procedural events used to detect breast cancer after screening mammography
    Patricia A Carney
    Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, NH 03756, USA
    AJR Am J Roentgenol 188:385-92. 2007
    ..The purpose of this study was to characterize the type and frequency of diagnostic evaluations after screening mammography and to summarize their association with the likelihood of biopsy and subsequent breast cancer diagnosis...
  60. ncbi Risk factors for mortality in middle-aged women
    Jeffrey A Tice
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, CA 94143, USA
    Arch Intern Med 166:2469-77. 2006
    ..Many factors contribute to mortality in older women, but their relative importance and independent contribution have been poorly characterized...
  61. ncbi Using probabilistic corrections to account for abstractor agreement in medical record reviews
    Timothy L Lash
    Boston University School of Public Health, Boston, MA 02118, USA
    Am J Epidemiol 165:1454-61. 2007
    ..While many investigators use reliability data only as a metric for data quality, a more thorough approach can also quantitatively depict the uncertainty in the observed associations...
  62. ncbi Mammography surveillance and mortality in older breast cancer survivors
    Timothy L Lash
    Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA
    J Clin Oncol 25:3001-6. 2007
    ..Our purpose is to estimate the effectiveness of surveillance mammography in a cohort of breast cancer survivors with complete ascertainment of surveillance mammograms and negligible losses to follow-up...
  63. ncbi Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population
    Karla Kerlikowske
    Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
    J Natl Cancer Inst 99:1335-9. 2007
    ....
  64. ncbi Under utilization of surveillance mammography among older breast cancer survivors
    Terry S Field
    Meyers Primary Care Institute, Worcester, MA 01605, USA
    J Gen Intern Med 23:158-63. 2008
    ..Annual surveillance mammography is recommended for follow-up of women with a history of breast cancer. We examined surveillance mammography among breast cancer survivors who were enrolled in integrated healthcare systems...
  65. ncbi An assessment of the quality of mammography care at facilities treating medically vulnerable populations
    L Elizabeth Goldman
    Department of Medicine, University of California, San Francisco, California 94143, USA
    Med Care 46:701-8. 2008
    ..Whether mammography facilities that treat vulnerable women demonstrate lower quality of care than other facilities is unknown...
  66. ncbi Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
    Cynthia Owusu
    Division of Hematology Oncology, Case Western Reserve University, University Hospitals Health System Ireland Cancer Center BHC 5055, 11100 Euclid Ave, Cleveland, OH 44106 5055, USA
    J Clin Oncol 26:549-55. 2008
    ..However, information on tamoxifen discontinuation is scanty. We sought to identify predictors of tamoxifen discontinuation among older women with breast cancer...
  67. ncbi Breast cancer treatment of older women in integrated health care settings
    Shelley M Enger
    Department of Research and Evaluation, Kaiser Permanente Medical Care Program, Pasadena, CA, USA
    J Clin Oncol 24:4377-83. 2006
    ..Information regarding treatment effectiveness in this age group and tools that allow physicians and patients to estimate the benefits versus the risks of therapies, taking into account age and comorbidity burden, are critically needed...
  68. ncbi Mortality impact of less-than-standard therapy in older breast cancer patients
    Marianne Ulcickas Yood
    Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
    J Am Coll Surg 206:66-75. 2008
    ....
  69. ncbi Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography
    Donald L Weaver
    Department of Pathology, University of Vermont, Burlington, 05405, USA
    Cancer 106:732-42. 2006
    ..To the authors' knowledge, a comprehensive analysis of pathology outcomes after screening mammography, as it is practiced clinically in the U.S. general population, has not been performed...
  70. ncbi Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study
    Susan E Andrade
    Meyers Primary Care Institute-Fallon Healthcare System and University of Massachusetts Medical School, Worcester, MA 01605, USA
    J Clin Epidemiol 55:310-3. 2002
    ..This study, using data from a large number of health plans located in different geographical regions, underscores the importance of evaluating the accuracy of the diagnoses from automated health plan databases...
  71. ncbi Survivorship research based in integrated healthcare delivery systems: the Cancer Research Network
    Ann M Geiger
    Division of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Cancer 112:2617-26. 2008
    ..The National Cancer Institute funds the Cancer Research Network (CRN) to leverage these capabilities for all types of cancer research, including survivorship...
  72. ncbi Gastric and duodenal safety of daily alendronate
    James G Donahue
    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Ave, Boston, MA 02115, USA
    Arch Intern Med 162:936-42. 2002
    ....
  73. ncbi Changes in newspaper coverage about hormone therapy with the release of new medical evidence
    Jennifer S Haas
    Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120 1613, USA
    J Gen Intern Med 21:304-9. 2006
    ..Differential coverage by lay newspapers may have contributed to the differential impact...
  74. ncbi Improving the concordance of mammography assessment and management recommendations
    Berta M Geller
    Office of Health Promotion Research, University of Vermont, 1 S Prospect St, Rm 4427D, Burlington, VT 05401 3444, USA
    Radiology 241:67-75. 2006
    ....
  75. ncbi Performance benchmarks for screening mammography
    Robert D Rosenberg
    Department of Radiology, University of New Mexico Health Sciences Center, MSC10 5530, USA
    Radiology 241:55-66. 2006
    ..S. radiologists to allow development of performance benchmarks for screening mammography...

Research Grants2

  1. BREAST CANCER SURVEILLANCE IN A DEFINED POPULATION
    Diana Buist; Fiscal Year: 2007
    ..abstract_text> ..